Stéphanie N. Q.
- Country
- France
- Department
- Hôpital Pitié Salpétrière - Service d'hématologie clinique
Research Overview
- Phase III Multicenter Trial of Allogeneic CD4+ and CD8+ T Lymphocytes for Chemo-Refractory CMV, EBV, and AdV Infections Post-Allogeneic Stem Cell Transplantation
- Evaluation of ASTX727 and Donor Lymphocyte Infusions Post-Allogeneic Stem Cell Transplantation in High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia
- Phase II Randomized Study of Methylprednisolone Hemisuccinate and Methoxsalen in Grade II Acute Graft-Versus-Host Disease Post-Allogeneic Stem Cell Transplantation
Data & Insights
Has run more than one trial at 7 of 35 partner sites.
Specializations
Stem Cell Transplantation
The investigator specializes in allogeneic hematopoietic stem cell transplantation with particular emphasis on treating blood disorders and managing transplant-related complications.
- Reduced intensity conditioning regimens
- Donor lymphocyte infusions
- Haplo-identical transplantation
Areas of focus include treatment optimization for elderly patients and high-risk cases.
Hematologic Conditions
Primary research interests center on treating acute myeloid leukemia and myelodysplastic syndrome, with additional expertise in rare blood disorders.
- Myelofibrosis management
- Pure red cell aplasia
- High-risk hematologic malignancies
Particular attention is given to developing innovative therapeutic approaches for treatment-resistant cases.
Transplant Complications
The investigator focuses on preventing and treating post-transplant complications, including graft-versus-host disease and viral infections.
- Microbiota transplantation
- Viral infection management
- GVHD prevention strategies
Research includes novel therapeutic approaches such as extracorporeal photopheresis and multispecific T-cell transfer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.